| Sigma Labs, Inc. | ||||||||
| Condensed Statements of Cash Flows | ||||||||
| (Unaudited) | ||||||||
| Three Months Ended | ||||||||
| March 31, 2018 | March 31, 2017 | |||||||
| OPERATING ACTIVITIES | ||||||||
| Net Loss | $ | (1,170,876 | ) | $ | (979,645 | ) | ||
| Adjustments to reconcile Net Loss to Net Cash used in operating activities: | ||||||||
| Noncash Expenses: | ||||||||
| Depreciation and Amortization | 47,320 | 46,149 | ||||||
| Stock Based Compensation | 161,522 | 140,671 | ||||||
| Loss on Write-off of Asset | 36,733 | - | ||||||
| Gain/Loss on Change in Derivative Balance | - | (93,206 | ) | |||||
| Original Issue Discount Amortization | - | 24,658 | ||||||
| Debt Discount Amortization | - | 56,441 | ||||||
| Change in assets and liabilities: | ||||||||
| Accounts Receivable | 32,343 | 130,882 | ||||||
| Interest Receivable | 22,438 | - | ||||||
| Inventory | 76,324 | (13,732 | ) | |||||
| Prepaid Assets | (1,938 | ) | 7,039 | |||||
| Accounts Payable | 164,930 | 167,845 | ||||||
| Deferred Revenue | 24,351 | 35,680 | ||||||
| Accrued Expenses | (5,396 | ) | 36,665 | |||||
| NET CASH USED IN OPERATING ACTIVITIES | (612,249 | ) | (440,553 | ) | ||||
| INVESTING ACTIVITIES | ||||||||
| Purchase of Property and Equipment | (16,565 | ) | (33,000 | ) | ||||
| Purchase of Intangible Assets | (39,542 | ) | (17,441 | ) | ||||
| Advance of Funds for Note Receivable | (500,000 | ) | ||||||
| Proceeds from Note Receivable and Related Accrued Interest | 500,000 | - | ||||||
| NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES | 443,894 | (550,441 | ) | |||||
| FINANCING ACTIVITIES | ||||||||
| Gross Proceeds from issuance of Common Stock and Warrants | - | 5,823,300 | ||||||
| Offering Costs Paid | - | (597,651 | ) | |||||
| NET CASH PROVIDED BY FINANCING ACTIVITIES | - | 5,225,649 | ||||||
| NET CHANGE IN CASH FOR PERIOD | (168,355 | ) | 4,234,655 | |||||
| CASH AT BEGINNING OF PERIOD | 1,515,674 | 398,391 | ||||||
| CASH AT END OF PERIOD | $ | 1,347,319 | $ | 4,633,046 | ||||
| Supplemental Disclosures: | ||||||||
| Other noncash operating activities disclosure: | ||||||||
| Issuance of Common Stock for services | $ | 40,000 | $ | 51,408 | ||||
| Disclosure of cash paid for: | ||||||||
| Interest | $ | - | $ | 20,114 | ||||
| Income Taxes | $ | - | $ | - | ||||
Sigma Labs Reports First Quarter 2018 Financial Results
 |  | More MCAD News
|
|
RELATED NEWS
